Item Type | Name |
Concept
|
Adenosine Triphosphatases
|
Concept
|
Adrenal Cortex Hormones
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
Family Health
|
Concept
|
Health Personnel
|
Concept
|
Heart Block
|
Concept
|
Heterozygote
|
Concept
|
Hippocampus
|
Concept
|
HLA Antigens
|
Concept
|
Homozygote
|
Concept
|
Humans
|
Concept
|
Immunohistochemistry
|
Concept
|
Kidney Diseases
|
Concept
|
Major Histocompatibility Complex
|
Concept
|
Molecular Biology
|
Concept
|
Pharmacogenetics
|
Concept
|
Plasma Exchange
|
Concept
|
Quality of Life
|
Concept
|
Research Design
|
Concept
|
Specimen Handling
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
HTLV-I Infections
|
Concept
|
HIV-1
|
Concept
|
HIV Infections
|
Concept
|
NF-kappa B
|
Concept
|
Sequence Homology, Amino Acid
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Hand Strength
|
Concept
|
Evidence-Based Medicine
|
Concept
|
Anti-HIV Agents
|
Concept
|
Heparan Sulfate Proteoglycans
|
Concept
|
Antiretroviral Therapy, Highly Active
|
Concept
|
Somatic Hypermutation, Immunoglobulin
|
Concept
|
Proteomics
|
Concept
|
Receptors, Natural Killer Cell
|
Concept
|
Seveso Accidental Release
|
Concept
|
Therapeutic Equipoise
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Academic Article
|
Immunotherapy of myositis: issues, concerns and future prospects.
|
Academic Article
|
Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
|
Academic Article
|
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
|
Academic Article
|
A critical update on the immunopathogenesis of Stiff Person Syndrome.
|
Academic Article
|
Electrophysiologic correlations with clinical outcomes in CIDP.
|
Academic Article
|
Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy.
|
Academic Article
|
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
|
Academic Article
|
Peripheral neuropathies in Sjogren syndrome: a new reappraisal.
|
Academic Article
|
Practical considerations on the use of rituximab in autoimmune neurological disorders.
|
Academic Article
|
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies.
|
Academic Article
|
Pathophysiology of inflammatory and autoimmune myopathies.
|
Academic Article
|
Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
|
Academic Article
|
Pathogenesis and therapies of immune-mediated myopathies.
|
Academic Article
|
Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece.
|
Academic Article
|
Potential biomarkers for monitoring therapeutic response in patients with CIDP.
|
Academic Article
|
Inflammatory myopathies: management of steroid resistance.
|
Academic Article
|
Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design.
|
Academic Article
|
Advances in the diagnosis, pathogenesis and treatment of CIDP.
|
Academic Article
|
Fatigue-Related Gene Networks Identified in CD14+ Cells Isolated From HIV-Infected Patients--Part II: Statistical Analysis.
|
Academic Article
|
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.
|
Academic Article
|
Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1ß-induced accumulation of ß-amyloid and cell death.
|
Academic Article
|
HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue.
|
Academic Article
|
Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis.
|
Academic Article
|
Fatigue-Related Gene Networks Identified in CD14+ Cells Isolated From HIV-Infected Patients--Part I: Research Findings.
|
Academic Article
|
Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.
|
Academic Article
|
Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins.
|
Academic Article
|
Inflammatory myopathies. Recent advances in pathogenesis and therapy.
|
Academic Article
|
Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.
|
Academic Article
|
Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin.
|
Academic Article
|
Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome?
|
Academic Article
|
GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM.
|
Academic Article
|
Immune mechanisms in chronic inflammatory demyelinating neuropathy.
|
Academic Article
|
Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.
|
Academic Article
|
Muscle biopsy findings in inflammatory myopathies.
|
Academic Article
|
Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations.
|
Academic Article
|
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record.
|
Academic Article
|
Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report.
|
Academic Article
|
Immunotherapy in autoimmune neuromuscular disorders.
|
Academic Article
|
Basic principles of immunotherapy for neurologic diseases.
|
Academic Article
|
Therapeutic approaches in patients with inflammatory myopathies.
|
Academic Article
|
Expression of IFN-gamma-inducible chemokines in inclusion body myositis.
|
Academic Article
|
Polymyositis and dermatomyositis.
|
Academic Article
|
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy.
|
Academic Article
|
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
|
Academic Article
|
Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy.
|
Academic Article
|
Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.
|
Academic Article
|
A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin.
|
Academic Article
|
Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
|
Academic Article
|
Intravenous immunoglobulin in autoimmune neuromuscular diseases.
|
Academic Article
|
From canine to man: on antibodies, macrophages, and dendritic cells in inflammatory myopathies.
|
Academic Article
|
Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
|
Academic Article
|
The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
|
Academic Article
|
The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: a view to the future from the "bench-to-bedside".
|
Academic Article
|
Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
|
Academic Article
|
Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?
|
Academic Article
|
Gene expression profiling in chronic inflammatory demyelinating polyneuropathy.
|
Academic Article
|
Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
|
Academic Article
|
A neuropsychological assessment of phobias in patients with stiff person syndrome.
|
Academic Article
|
Brain gamma-aminobutyric acid changes in stiff-person syndrome.
|
Academic Article
|
The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.
|
Academic Article
|
Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy.
|
Academic Article
|
Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.
|
Academic Article
|
Molecular pathogenesis of inflammatory myopathies and future therapeutic strategies.
|
Academic Article
|
Single nucleotide polymorphisms in the dystroglycan gene do not correlate with disease severity in hereditary inclusion body myopathy.
|
Academic Article
|
Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands.
|
Academic Article
|
Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
|
Academic Article
|
Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.
|
Academic Article
|
Inflammatory, immune, and viral aspects of inclusion-body myositis.
|
Academic Article
|
The role of high-dose immune globulin intravenous in the treatment of dermatomyositis.
|
Academic Article
|
Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.
|
Academic Article
|
B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
|
Academic Article
|
Variable pathogenic potentials of mutations located in the desmin alpha-helical domain.
|
Academic Article
|
Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.
|
Academic Article
|
Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.
|
Academic Article
|
A comparison of fatigue scales in postpoliomyelitis syndrome.
|
Academic Article
|
Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome.
|
Academic Article
|
Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
|
Academic Article
|
Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.
|
Academic Article
|
The challenge of diagnosing ALS in patients with prior poliomyelitis.
|
Academic Article
|
Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins.
|
Academic Article
|
Absence of upregulated genes associated with protein accumulations in desmin myopathy.
|
Academic Article
|
Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study.
|
Academic Article
|
Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge.
|
Academic Article
|
Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
|
Academic Article
|
Macroautophagy as a pathomechanism in sporadic inclusion body myositis.
|
Academic Article
|
Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
|
Academic Article
|
Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis.
|
Academic Article
|
Advances in the immunobiology and treatment of inflammatory myopathies.
|
Academic Article
|
High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome.
|
Academic Article
|
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
|
Academic Article
|
Advances in the pathogenesis and treatment of patients with stiff person syndrome.
|
Academic Article
|
A focused microarray to study human mitochondrial and nuclear gene expression.
|
Academic Article
|
Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.
|
Academic Article
|
Invited article: inhibition of B cell functions: implications for neurology.
|
Academic Article
|
Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation".
|
Academic Article
|
IVIg in other autoimmune neurological disorders: current status and future prospects.
|
Academic Article
|
A "nema" of hope in the treatment of late-onset nemaline myopathy.
|
Academic Article
|
Autoimmune inflammatory myopathies.
|
Academic Article
|
B cells as therapeutic targets in autoimmune neurological disorders.
|
Academic Article
|
In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy.
|
Academic Article
|
Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.
|
Academic Article
|
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.
|
Academic Article
|
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
|
Academic Article
|
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.
|
Academic Article
|
Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease.
|
Academic Article
|
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study.
|
Academic Article
|
Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?
|
Academic Article
|
Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.
|
Academic Article
|
Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study.
|
Academic Article
|
Validity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositis.
|
Academic Article
|
Lower extremity peak force and gait kinematics in individuals with inclusion body myositis.
|
Academic Article
|
Reliability of the adult myopathy assessment tool in individuals with myositis.
|
Academic Article
|
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
|
Academic Article
|
HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
|
Academic Article
|
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
|
Academic Article
|
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
|
Academic Article
|
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
|
Academic Article
|
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.
|
Academic Article
|
Viruses in IBM: Hit-and-run, hide and persist, or irrelevant?
|
Academic Article
|
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
|
Academic Article
|
Treating myasthenia on consensus guide: Helpful and challenging but still unfinished business.
|
Academic Article
|
Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost.
|
Academic Article
|
Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy.
|
Academic Article
|
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
|
Academic Article
|
Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system.
|
Academic Article
|
Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder.
|
Academic Article
|
IVIG efficacy in CIDP patients is not associated with terminal complement inhibition.
|
Academic Article
|
Trial of canakinumab, an IL-1ß receptor antagonist, in patients with inclusion body myositis.
|
Academic Article
|
Case 22-2019: A 65-Year-Old Woman with Myopathy.
|
Academic Article
|
N2 year in review.
|
Academic Article
|
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort.
|
Academic Article
|
Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
|
Academic Article
|
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
|
Academic Article
|
A HSCT TRIAL IN STIFF PERSON SYNDROME: LIMITED BENEFITS HALT ENROLLMENT BUT SHOULD BE MORE TO COME?
|
Academic Article
|
N2 year in review.
|
Academic Article
|
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece.
|
Academic Article
|
Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications.
|
Academic Article
|
Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.
|
Academic Article
|
Aggressive Herpes Zoster in Young Patients With Multiple Sclerosis Under Dimethyl Fumarate: Significance of CD8+ and Natural Killer Cells.
|
Academic Article
|
Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data.
|
Academic Article
|
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.
|
Academic Article
|
Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID.
|
Academic Article
|
Unconvincing Evidence of SARS-CoV-2-Associated Myositis in Autopsied Muscles.
|